Policy
An unnamed FDA official also told reporters that it would be good for Moderna to “show some humility” and admit that it didn’t follow the regulator’s recommendations in testing its mRNA flu vaccine.
FEATURED STORIES
Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are keeping many of the terms of their agreements private.
Some 200 rare disease therapies are at risk of losing eligibility for a pediatric priority review voucher, a recent analysis by the Rare Disease Company Coalition shows. That could mean $4 billion in missed revenue for already cash-strapped biotechs.
The FDA’s rare pediatric disease priority review voucher program missed reauthorization at the last minute in 2024; advocates have been fighting to get it back ever since.
Subscribe to BioPharm Executive
Market insights and trending stories for biopharma leaders, in your inbox every Wednesday
THE LATEST
Dr. Amin Al Amiri: the Programs are part of ministry’s initiatives during ‘Year of Zayed’ to provide quality of care to patients
Epigenomics AG today announced that the U.S. Congress urges the Centers of Medicare & Medicaid Services (CMS) to consider coverage of colorectal cancer screening blood tests as part of the approved 2019 Health and Human Services (HHS) Appropriations Bill.
Almac Group is pleased to announce the successful inspection of Almac Pharma Services (Ireland) at its European campus in Dundalk, Ireland, by the Health Products Regulatory Authority (HPRA).
In September OptiBiotix signs three more agreements
Certificate from AGES, the Austrian Agency for Health and Food Safety, endorses GMP conformity to Rentschler Fill Solutions’ new top-of-class facility.
Following the U.S. Drug Enforcement Agency’s rescheduling of GW Pharmaceuticals’ Epidiolex from a Schedule I to a Schedule V, other cannabis-based drug development companies believe there is momentum for their medications to gain regulatory approval.
Ministry presents initiatives at 12th International Law Enforcement Intellectual Property Crime Conference
One-year scheme under ATAA & TADAMON initiatives for financially challenged patients
Initiative highlights commitment to the highest health and safety standards in the workplace in cooperation with the American Hospital in Dubai
German chemical company BASF, the world’s largest chemical producer, has registered 47 percent of patented marine organism gene sequences, according to a study published in Science Advances in June.